Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

The FDA has approved Adcetris (brentuximab vedotin) for use in combination with lenalidomide and rituximab to treat patients with relapsed/refractory LBCL after 2 or more lines of systemic therapy who ...

Takeda and Seattle Genetics are closing in on a new front-line use for their Adcetris in classical Hodgkin lymphoma after a successful late-stage trial. The positive results from the phase 3 ...

On Thursday, Jones announced that her cancer, diagnosed earlier this month, is Stage 4 Hodgkin’s Lymphoma. She said she is using the strength she once found on the basketball court to continue living.

Pfizer’s Adcetris combination regimen gets US FDA approval to treat relapsed/refractory diffuse large B-cell lymphoma: New York Friday, February 14, 2025, 11:00 Hrs [IST] Pfizer ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...

The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).

Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.

This is the cold season, and many people are down with runny nose, fever, cough, and tiredness. However, according to experts ...

Patients treated in community settings were more likely to be older, less likely to be White, and had worse survival rates, ...

WWNO is New Orleans’ source for 24-hour classical music available on standard FM radios in New Orleans and the Eastbank and Westbank suburbs on Classical 104.9FM. You can also find us on your HD ...